Co-Incubation of Lymphocytes with Fibroblast-Like Synoviocytes and other Cell Types Can Induce Lymphocytic Surface Expression of Aminopeptidase N/CD13

  • Dagmar Riemann
  • Astrid Kehlen
  • Katja Thiele
  • Matthias Löhn
  • Jürgen Langner
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 421)


Aminopeptidase N (APN, EC is an ubiquitously occurring transmembrane ectoenzyme. Sequence comparisons of the cloned cDNA showed that APN is identical to CD13 antigen1. The coding part of the CD13 gene is encoded by 20 exons2. CD13 has been considered to be a myeloid-specific marker because lymphocytes of peripheral blood and tonsills always are CD13 negative. However, we have previously demonstrated the expression of CD l3 on synovial T cells from patients with different forms of arthritis3 or on tumor-infiltrating lymphocytes from renal cell carcinoma4. To learn more about conditions in tissues resulting in the expression of CD13 on lymphocytes, we incubated tonsillar T and B cells as well as peripheral blood lympho-cytes (PBL) with various mediators in the absence and presence of different stromal cells.


CD13 mRNA Human Renal Cell Carcinoma Human Renal Cell Carcinoma Cell Kidney Tubular Epithelial Cells11 Natural Killer Cell Surface 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Look AT. Ashmun RA, Shapiro LH, Peiper SC (1989) Human myeloid plasma membrane glycoprotein CD13 (gp 150) is identical to aminopeptidase N. J Clin Invest 83: 1299–1307CrossRefGoogle Scholar
  2. 2.
    Lerche C, Vogel LK, Shapiro LH, Noren O. Sjöström H (1996) Mamm Genome 712–713.Google Scholar
  3. 3.
    Riemann D, Schwachula A, Hentschel M, Langner J (1993) Demonstration of CD13iaminopeptidase N on synovial fluid T cells from patients with different forms of joint effusions. Immunobiol 187: 24–35.Google Scholar
  4. 4.
    Riemann D, Göhring B, Langner J (1994) Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma. Immunol Lett 42: 19–23.PubMedCrossRefGoogle Scholar
  5. 5.
    Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F (1991) Long term human B cell lines dependent on interleukin 4 and anti-CD40. Science 251: 70–72.PubMedCrossRefGoogle Scholar
  6. 6.
    Scott S, Pandolfi F, Kurnick T (1990) Fibroblasts mediate T cell survival: A proposed mechanism for retention of primed cells. J Exp Med 172: 1873–1876.Google Scholar
  7. 7.
    Dechanet J, Merville P, Durand I, Banchereau J, Miossec P (1995) The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulaltion in rheumatoid synovium. J Clin Invest 95: 456–463.PubMedCrossRefGoogle Scholar
  8. 8.
    Riemann D, Kehlen A, Thiele K, Löhn M, Langner J (1997) Induction of aminopeptidase N/CD13 on human lymphocytes upon adhesion to fibroblast-like synoviocytes, endothelial cells, epithelial cells and monocytes/macrophages. 1 Immunol in press.Google Scholar
  9. 9.
    Schwachula A, Riemann D, Kehlen A, Langner J (1994) Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells. Immunobiol 190: 67–92.CrossRefGoogle Scholar
  10. 10.
    Riemann D. Wollert H-G, Menschikowski J. Mittenzwei S, Langner.1 (1994) Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allerg Immunol 104: 48–56.Google Scholar
  11. 11.
    Riemann D, Kehlen A, Langner J (1995) Stimulation of the expression and the enzyme activity of aminopeptidase N/CDI3 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin Exp. Immun 100: 277–283.Google Scholar
  12. 12.
    Wex T, Lendeckel U, Wex H, Frank K, Ansorge S (1995) Quantification of aminopeptidase N mRNA in T cells by competitive PCR. FIBS Lett 374: 341–344.Google Scholar
  13. I3. Wex T, Lendeckel U, Reinhold D, Kühne T, Arndt M, Frank K, Ansorge S (1996) Antisense-mediated inhibition of aminopeptidase N (CD13) markedly decreases growth rates of hematopoictic tumour cells. Chapter in this book.Google Scholar
  14. 14.
    Sanderink GJ, Artur Y, Siest G (1988) Human aminopeptidases. A review of the literature. J Clin Chem Clin Biochem 26: 795–807.Google Scholar
  15. 15.
    Amoscato AA, Spiess RR, Sansoni SB, Herberman RB, Chambers WH (1993) Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases. Brain Behav Immunity 7: 176–179.CrossRefGoogle Scholar
  16. 16.
    Kanayama N, Kajiwara Y, Goto E, El Maradny E, Macharak. Andou K. Terco T (1995) Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukocyte Biol 57: 129–134.PubMedGoogle Scholar
  17. I7. Menrad A, Speicher D, Walker J, Herlyn M (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 53: 1450–1455.Google Scholar
  18. 18.
    Saiki I, Fujii H, Yoneda H, Abe F, Nakajima M, Tsuruo T, Azuma I (1993) Role of aminopeptidase N (CD 13) in tumor-cell in vasion and extracellular matrix degradation. Int J Cancer 54: 137–143.Google Scholar
  19. 19.
    Larsen SL, Ostergaard L, Buus S, Stryhn A (1996) T cells responses affected by aminopeptidase N (CD13)mediated trimming of major histocompatibility complex class II - bound peptides. J I?xp Med 184: 183–189.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Dagmar Riemann
    • 1
  • Astrid Kehlen
    • 1
  • Katja Thiele
    • 1
  • Matthias Löhn
    • 1
  • Jürgen Langner
    • 1
  1. 1.Institute of Medical ImmunologyMartin Luther University HalleHalleGermany

Personalised recommendations